Skip to content
Open access

Integrated Pan-Cancer, Single-Cell, and Spatial Transcriptomic Analyses Identify ZDHHC12 as a Biomarker Associated with Macrophage Infiltration and the Immune Landscape in Glioma

Sep 2026 · Journal of Cancer · Vol 17, pp. 1653 - 1670 · 0 citations · 47 references
Medicine

TL;DR

ZDHHC12 may serve as a candidate pan-cancer prognostic biomarker and its expression was broadly correlated with immune cell recruitment- and activation-related signatures in glioma and in glioma, and was associated with patient prognosis.

Abstract

Background The tumor immune microenvironment (TME) critically influences cancer progression and therapeutic response. However, the pan-cancer expression landscape, prognostic relevance, and spatial distribution of ZDHHC12 remain incompletely characterized. This study investigated the prognostic value of ZDHHC12 and its associations with immune microenvironmental features and drug sensitivity. Methods Data from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) datasets were used to evaluate ZDHHC12 expression and prognosis across cancer types. Immune infiltration analyses, single-cell RNA sequencing, and spatial transcriptomics were integrated to characterize the associations of ZDHHC12 with the cancer immunity cycle and the spatial architecture of glioma. Drug sensitivity and immunotherapy-related metrics were assessed using pharmacogenomic databases and computational prediction models. Results ZDHHC12 was aberrantly expressed across multiple tumors and was associated with patient prognosis. Its expression was broadly correlated with immune cell recruitment- and activation-related signatures. In glioma, single-cell and spatial transcriptomic analyses showed enrichment of ZDHHC12 in monocyte/macrophage populations and spatial co-localization with BAK1, CD68, and CD163. ZDHHC12 expression was also associated with predicted drug sensitivity and immunotherapy-related metrics. Conclusion ZDHHC12 may serve as a candidate pan-cancer prognostic biomarker. In glioma, its expression is associated with macrophage-enriched and immunosuppressive microenvironmental features. Functional studies are required to establish causality and determine its therapeutic relevance.

Read PDF

Similar papers

Open access Sep 2026

Identification of FN1 and TIMP1 as macrophage-associated programmed cell death-related prognostic markers in glioblastoma via integrated bulk and single-cell RNA sequencing

The risk model based on FN1 and TIMP1 are identified as pivotal MacPCD-related prognostic genes in GBM, offering a reliable tool for clinical prognosis and paving the way for personalized immunotherapy strategies.

Feng Li, Cai-Feng Wang, Zhe-Sen Tian et al. · 0 citations
Open access Sep 2026

Multi-omics characterization of P2RX4-associated immune microenvironment features and proof-of-concept observations of peritumoral radiomic phenotypes in TNBC

In the analyzed TNBC datasets, P2RX4 expression was associated with CD163 expression and hypoxia-related transcriptional features, and across transcriptomic analyses, P2RX4 expression was positively associated with CD163 expression and hypoxia-related transcriptional features.

Yi-Fei Meng, Yong-Qiu Zhu, Yue Zhang et al. · 0 citations
Sep 2026

ARHGAP22 as a Potential Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: Insights into Tumor Immunity and Co-Expression Networks.

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer and is characterized by substantial clinical heterogeneity, highlighting the need for reliable prognostic biomarkers. This study evaluated the expression pattern, prognostic relevance, and immune-related associations of ARHGAP22 in ccRC...

Yong-Zhuo Li, He Duan, Li Su et al. · 0 citations
Open access Oct 2026

Pan-cancer and experimental analyses reveal TTC39B as a suppressor of cell proliferation in clear cell renal cell carcinoma

Tetratricopeptide repeat domain protein 39B (TTC39B) is a lipid metabolism–related gene recently implicated in cholesterol regulation. However, its clinical and biological relevance in human cancers remains undefined. Based on multi-omics data from the Cancer Genome Atlas (TCGA) pan-cancer dataset represen...

Hui-Juan Yi, Yan Wang, Chen-Hao Zhao et al. · 0 citations
Open access Aug 2026

Single-cell transcriptomics deciphers cancer-associated fibroblast heterogeneity and immune regulatory mechanisms in the bladder cancer tumor microenvironment

Single-cell transcriptomics of publicly available BLCA data identifies two transcriptionally distinct fibroblast states in adjacent tissue and supports an exploratory ligand–receptor interaction framework, warranting prospective validation with primary CAF populations and adequately powered multi-specimen cohorts.

Yan-Dong He, Wen-Long Lu, Guan-Qun Ju et al. · 0 citations
Open access Aug 2026

Development of an immune escape-related gene prognostic signature using integrated single-cell and bulk RNA sequencing for immune microenvironment profiling in thyroid cancer.

A single-cell-informed immune escape signature provides a promising framework for thyroid carcinoma risk stratification and offers insights into personalized immunotherapy.

Ling Jiang, Liu-Yi Zou, Fei-Qi Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.